Evidence map›Paper›PMID 36421991›Full record

ArticleMarine drugs2022

A Metabolomics-Based Toolbox to Assess and Compare the Metabolic Potential of Unexplored, Difficult-to-Grow Bacteria.

Federica Fiorini, Felizitas Bajerski, Olga Jeske, Cendrella Lepleux, Jörg Overmann, Mark Brönstrup

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Federica FioriniDepartment of Chemical Biology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.
Felizitas BajerskiLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (DSMZ), 38124 Braunschweig, Germany.
Olga JeskeLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (DSMZ), 38124 Braunschweig, Germany.
Cendrella LepleuxLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (DSMZ), 38124 Braunschweig, Germany.ORCID 0000-0003-3347-2090
Jörg OvermannLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (DSMZ), 38124 Braunschweig, Germany.ORCID 0000-0003-3909-7201
Mark BrönstrupDepartment of Chemical Biology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.ORCID 0000-0002-8971-7045
Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures · DEGerman Center for Infection Research · DEHelmholtz Centre for Infection Research · DELeibniz University Hannover · DE

Funding

European Union's Horizon 2020 54008, EMBRIC
6 · The paper itself

Abstract

Novel high-throughput cultivation techniques create a demand to pre-select strains for in-depth follow-up studies. We report a workflow to identify promising producers of novel natural products by systematically characterizing their metabolomes. For this purpose, 60 strains from four phyla (Proteobacteria, Bacteroidetes, Actinobacteria and Firmicutes) comprising 16 novel species and six novel genera were cultivated from marine and terrestrial sources. Their cellular metabolomes were recorded by LC-MS/MS; data analysis comprised databases MS/MS matching, in silico compound assignment, and GNPS-based molecular networking. Overall, 1052 different molecules were identified from 6418 features, among them were unusual metabolites such as 4-methoxychalcone. Only a minor portion of the 755 features were found in all phyla, while the majority occurred in a single phylogroup or even in a single strain. Metabolomic methods enabled the recognition of highly talented strains such as AEG42_45, which had 107 unique features, among which a family of 28 potentially novel and related compounds according to MS/MS similarities. In summary, we propose that high-throughput cultivation and isolation of bacteria in combination with the presented systematic and unbiased metabolome analysis workflow is a promising approach to capture and assess the enormous metabolic potential of previously uncultured bacteria.

Indexed as

MetabolomicsTandem Mass SpectrometryBacteriaChromatography, LiquidMetabolomedifficult-to-grow bacteriaLC-MS/MSnatural productsnovel bacterial strainsuntargeted metabolomics

Identifiers

PMID36421991
PMCPMC9698959
OpenAlexW4309742205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.